動物胎盤蛋白市場－全球產業規模、佔有率、趨勢、機會及預測（依產品類型、應用、動物來源、通路、地區及競爭格局分類，2021-2031年）

全球動物胎盤蛋白市場預計將從 2025 年的 5.4462 億美元成長到 2031 年的 7.4075 億美元，複合年成長率為 5.26%。

這種生物活性成分提取自豬、羊、馬等哺乳動物的產後組織，因其富含酵素、氨基酸和生長因子而備受推崇。市場成長主要受藥用化妝品產業以及老齡化醫學在組織修復領域日益廣泛的應用所驅動。此外，消費者對富含營養的器官來源膳食補充劑的興趣日益濃厚，也進一步推動了對這些特殊蛋白質組分的商業性需求。

然而，由於嚴格的法規旨在防止疾病傳播並確保動物產品的生物安全，該行業面臨許多挑戰。根據中國畜牧業協會的數據顯示，為因應市場供應過剩，2024年，該產業策略性地減少了約100萬頭種母豬的數量。此舉直接限制了豬胎盤蛋白原料的供應。牲畜數量的這種波動給依賴豬源原料維持穩定產量的生產者帶來了巨大挑戰。

市場促進因素

全球動物胎盤蛋白市場的主要驅動力是消費者對活膚和抗衰老齡化化妝品日益成長的需求。隨著消費者越來越傾向於非侵入性美容方式，能夠刺激膠原蛋白合成並加速術後恢復的生物活性成分的使用量也相應激增。國際美容整形外科學會（ISAPS）2024年6月的資料印證了這個趨勢。該學會報告稱，上年度全球共進行了1,910萬例非手術美容項目，為含有胎盤成分的術後護理產品奠定了堅實的市場基礎。製造商們積極響應，將蛋白質組分添加到化妝品中，以模擬臨床治療的再生效果，從而推動了胎盤萃取物的大規模採購。

同時，傷口護理和再生醫學領域應用的不斷拓展也推動了市場成長。在這些領域，動物性支架對於組織工程至關重要。近期臨床研究證實了這些生物基質對複雜皮膚創傷的有效性，使其在臨床應用中得到更廣泛的認可。例如，2024年12月發表於《Cureus》雜誌的一項真實世界研究表明，豬胎盤來源的細胞外基質可促進53%難癒合傷口的完全癒合，凸顯了其治療價值。為了保障這些醫療級應用，供應鏈保持穩健。根據紐西蘭鹿業局報告，截至2024年9月的財政年度，鹿產品（一種重要的生物活性成分提取原料）的出口量達到4944噸，確保了治療領域所需高品質原料的穩定供應。

市場挑戰

市場成長的主要障礙是原料供應鏈不均衡，這主要是由於全球牲畜存欄量的波動所造成的。動物胎盤蛋白的生產完全依賴產後組織的採集，因此對馬、羊和豬等畜群規模的減少極為敏感。經濟因素、疾病爆發和監管性畜群管理措施導致的族群數量減少，進而降低了可提取的生物材料量。這種依賴性造成了嚴重的生產瓶頸，使得生產商難以維持滿足不斷成長的商業需求所需的庫存水準。

根據美國綿羊產業協會預測，到2024年，美國綿羊和羔羊總數預計將下降2%，這意味著羊源原料的供應來源將持續萎縮。生物基礎的下降直接限制了羊源原料的供給能力。因此，生產商必須應對日益激烈的資源競爭和不斷上漲的採購成本，這不僅阻礙了他們的擴張，也減緩了胎盤蛋白產業的整體成長。

市場趨勢

豬胎盤蛋白在韓國化妝品的應用正顯著成長，重塑市場格局。這主要得益於該成分與人體皮膚的高組織相容性以及韓妝品牌的全球擴張。隨著製造商不斷改進安瓿和面膜產品以充分利用其親和性，成品出口量也隨之激增。為了滿足國際需求，需要大量採購豬源性原料。韓國海關2025年1月的貿易數據顯示，2024年韓國對美國的護膚品出口額成長超過三倍，達到8.151億美元，印證了這個趨勢。這凸顯了富含胎盤蛋白的產品進入西方市場的巨大商業潛力。

同時，面向中東和東南亞等監管嚴格的市場的清真認證羊胎盤萃取物正在迅速湧現。為了確保符合宗教要求，生產商正加速以羊源性替代品取代豬源性成分，這項策略得益於澳洲等主要出口國創紀錄的高生物利用度。這種供給能力對於滿足清真要求至關重要。根據澳洲肉類（MLA）2024年9月發布的《羊業預測》報告，預計到2024年6月，澳洲國內羊群數量將達到7,910萬隻，為2007年以來的最高水平，這將為這些特殊配方提供可追溯且穩定的原料來源。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球動物胎盤蛋白市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品類型（萃取物、粉末、膠囊/片劑、注射劑）
  • 依應用領域（藥品、化妝品及個人保健產品、營養保健品及膳食補充品、研究、生物技術）
  • 動物種類（牛、豬、羊、馬、其他）
  • 依分銷通路（直銷、零售、線上零售）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美動物胎盤蛋白市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲動物胎盤蛋白市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區動物胎盤蛋白市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲動物胎盤蛋白市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美動物胎盤蛋白市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球動物胎盤蛋白市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Merck KGaA
• Biotain Pharma Co., Ltd.
• New Zealand Health Food Company Limited
• XABC Biotech Co., Ltd.
• Chaitanya Biologicals Pvt. Ltd.
• Serolab SA
• Auckland BioSciences Limited
• ANZCO Foods Limited
• Biocontinental Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Animal Placental Protein Market is projected to expand from USD 544.62 Million in 2025 to USD 740.75 Million by 2031, registering a CAGR of 5.26%. This bioactive ingredient, derived from the postpartum tissues of mammals like swine, sheep, and horses, is prized for its rich content of enzymes, amino acids, and growth factors. The market's growth is largely fueled by the booming cosmeceutical industry, which demands potent anti-aging ingredients, and the rising application of regenerative therapies for tissue repair. Furthermore, increasing consumer interest in nutrient-rich, organ-based dietary supplements is strengthening commercial demand for these specialized protein fractions.

However, the sector encounters significant obstacles arising from strict regulations designed to prevent disease transmission and ensure the biological safety of animal by-products. Data from the China Animal Agriculture Association indicates that in 2024, the industry strategically reduced the breeding sow herd by roughly 1 million heads to manage market oversupply, a move that directly limits the availability of raw materials for porcine placental protein. This variability in livestock numbers poses a considerable challenge for manufacturers who depend on porcine sources to maintain stable production volumes.

Market Driver

A primary catalyst for the global animal placental protein market is the escalating demand for skin rejuvenation and anti-aging cosmetic products. With consumers increasingly favoring non-invasive aesthetic improvements, there is a corresponding surge in the use of bioactive ingredients that promote collagen synthesis and accelerate post-procedure recovery. This trend is supported by June 2024 data from the International Society of Aesthetic Plastic Surgery, which reported 19.1 million non-surgical procedures globally in the previous year, establishing a strong market for placenta-infused aftercare solutions. Manufacturers are responding by incorporating protein fractions into cosmeceuticals that replicate the regenerative benefits of clinical treatments, driving substantial procurement of raw extracts.

Simultaneously, the market is bolstered by growing applications in wound care therapeutics and regenerative medicine, where animal-derived scaffolds are crucial for tissue engineering. Recent clinical progress has confirmed the effectiveness of these biological matrices for complex skin injuries, enhancing their medical acceptance. For example, a real-world study published in Cureus in December 2024 showed that porcine placental extracellular matrix facilitated complete closure in 53% of hard-to-heal wounds, highlighting its therapeutic value. To sustain these medical-grade uses, the supply chain remains robust; Deer Industry New Zealand reported that exports of deer co-products, a vital source for bioactive extraction, reached 4,944 tonnes in the year ending September 2024, ensuring the high-quality raw material availability needed for the therapeutic sector.

Market Challenge

The main obstacle to market growth is the inconsistency of raw material supply chains caused by fluctuations in global livestock inventories. Because animal placental protein production depends entirely on collecting postpartum tissue, the industry is highly sensitive to any reductions in equine, ovine, or swine herd sizes. When breeding populations shrink due to economic factors, disease outbreaks, or regulatory herd management, the quantity of extractable biological material falls. This reliance creates major production bottlenecks, making it difficult for manufacturers to maintain the inventory levels necessary to satisfy increasing commercial demand.

According to the American Sheep Industry Association, the total inventory of sheep and lambs in the United States fell by 2 percent in 2024, indicating a persistent contraction in ovine sources. This decline in the biological foundation directly limits the supply capacity for ingredients derived from sheep. Consequently, manufacturers must contend with intensified competition for scarce resources and rising procurement costs, which hinders their ability to expand operations and slows the overall growth of the placental protein sector.

Market Trends

The market is being reshaped by a marked increase in the use of porcine-derived placental protein in Korean cosmetic formulations, driven by the ingredient's strong histocompatibility with human skin and the global reach of K-Beauty brands. As manufacturers update ampoules and sheet masks to leverage this biological affinity, exports of these finished products have surged, requiring greater volumes of porcine raw materials to fulfill international demand. This trend is confirmed by trade data from the Korea Customs Service in January 2025, which notes that skincare exports to the United States more than tripled to $815.1 million in 2024, highlighting the massive commercial channel through which these placenta-enriched products are entering Western markets.

Concurrently, there is a rapid emergence of Halal-certified ovine placenta extracts aimed at strictly regulated consumer markets in the Middle East and Southeast Asia. To ensure religious compliance, producers are increasingly replacing porcine ingredients with sheep-derived alternatives, a strategy supported by record biological availability from major exporters like Australia. This supply capacity is essential for meeting Halal requirements; according to Meat & Livestock Australia's September 2024 'Sheep Industry Projections' report, the national flock peaked at 79.1 million head in June 2024, the highest level since 2007, providing a traceable and stable raw material base for these specialized formulations.

Key Market Players

• Merck KGaA
• Biotain Pharma Co., Ltd.
• New Zealand Health Food Company Limited
• XABC Biotech Co., Ltd.
• Chaitanya Biologicals Pvt. Ltd.
• Serolab SA
• Auckland BioSciences Limited
• ANZCO Foods Limited
• Biocontinental Co., Ltd.

Report Scope

In this report, the Global Animal Placental Protein Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Placental Protein Market, By Product Type

• Extracts
• Powders
• Capsules/Tablets
• Injections

Animal Placental Protein Market, By Application

• Pharmaceuticals
• Cosmetics and Personal Care Products
• Nutraceuticals and Dietary Supplements
• Research
• Biotechnology

Animal Placental Protein Market, By Animal Source

• Bovine
• Porcine
• Ovine
• Equine
• Others

Animal Placental Protein Market, By Distribution Channel

• Direct Sales
• Retail Sales
• Online Retail

Animal Placental Protein Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Placental Protein Market.

Available Customizations:

Global Animal Placental Protein Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Placental Protein Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Extracts, Powders, Capsules/Tablets, Injections)
  • 5.2.2. By Application (Pharmaceuticals, Cosmetics and Personal Care Products, Nutraceuticals and Dietary Supplements, Research, Biotechnology)
  • 5.2.3. By Animal Source (Bovine, Porcine, Ovine, Equine, Others)
  • 5.2.4. By Distribution Channel (Direct Sales, Retail Sales, Online Retail)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Animal Placental Protein Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By Animal Source
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Animal Placental Protein Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Animal Source
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Canada Animal Placental Protein Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Animal Source
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Mexico Animal Placental Protein Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Animal Source
      • 6.3.3.2.4. By Distribution Channel

7. Europe Animal Placental Protein Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By Animal Source
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Animal Placental Protein Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Animal Source
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. France Animal Placental Protein Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Animal Source
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Animal Placental Protein Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Animal Source
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Animal Placental Protein Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Animal Source
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Animal Placental Protein Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Animal Source
      • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Animal Placental Protein Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By Animal Source
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Animal Placental Protein Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Animal Source
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Animal Placental Protein Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Animal Source
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. Japan Animal Placental Protein Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Animal Source
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. South Korea Animal Placental Protein Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Animal Source
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Animal Placental Protein Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Animal Source
      • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Animal Placental Protein Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By Animal Source
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Animal Placental Protein Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Animal Source
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. UAE Animal Placental Protein Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Animal Source
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. South Africa Animal Placental Protein Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Animal Source
      • 9.3.3.2.4. By Distribution Channel

10. South America Animal Placental Protein Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By Animal Source
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Animal Placental Protein Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Animal Source
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Colombia Animal Placental Protein Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Animal Source
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. Argentina Animal Placental Protein Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Animal Source
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Animal Placental Protein Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Merck KGaA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Biotain Pharma Co., Ltd.
• 15.3. New Zealand Health Food Company Limited
• 15.4. XABC Biotech Co., Ltd.
• 15.5. Chaitanya Biologicals Pvt. Ltd.
• 15.6. Serolab SA
• 15.7. Auckland BioSciences Limited
• 15.8. ANZCO Foods Limited
• 15.9. Biocontinental Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer